Henry Ji

Henry Ji

Directeur Général chez SCILEX HOLDING COMPANY

Fortune : 129 101 $ au 31/07/2026

61 ans
Health Technology
Consumer Services
Commercial Services

Profil

Henry H.
Ji
was the founder of Sorrento Therapeutics, Inc., founded in 1989, serving as Chairman, President & Chief Executive Officer since 2017 and currently as Director & Chief Scientific Officer.
Dr. Ji is the founder of BioVintage, Inc., founded in 2002, serving as President since 2002.
Dr. Ji was the founder of Stratagene Genomics, Inc., founded in 1997, serving as President, Chief Executive Officer & Director from 1997 to 1999.
Dr. Ji currently serves as Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc. Dr. Ji currently serves as Executive Chairman, President & CEO at Semnur Pharmaceuticals, Inc. starting 2026.
Dr. Ji currently serves as Chief Executive Officer & Secretary at Semnur, Inc. since 2013.
Dr. Ji currently serves as Executive Chairman, President & CEO at Scilex Holding Co. starting 2025.
Dr. Ji currently serves as Chief Executive Officer at Oqory, Inc. Dr. Ji currently serves as Director at Scilex Pharmaceuticals, Inc. since 2019.
Dr. Ji currently serves as Director at Elsie Biotechnologies Inc. Dr. Ji currently serves as Director at JP 3E Holdings, Inc. starting 2026.
Former positions include Executive Chairman at Scilex, Inc. from 2019 to 2022; Executive Chairman at Scilex Holding Co. from 2019 to 2023; Director at NantKwest, Inc. from 2014 to 2015; Director-Business Development at Stratagene Corp.
from 1999 to 2001; Managing Director at Hongye SD Group LLC; Director at Celularity, Inc. (United States) from 2017 to 2021; Vice President at CombiMatrix Corp.
from 2001 to 2002; Secretary & Chief Scientific Officer at Quikbyte Software, Inc. in 2009.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from Fudan University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/04/2026 19 370 ( 0,23 % ) 129 101 $ 31/07/2026
-.--%
17/04/2026 0 ( -.--% ) - $ 31/07/2026

Postes actifs de Henry Ji

SociétésPosteDébut
SORRENTO THERAPEUTICS, INC. Directeur Général 01/04/2011
SCILEX HOLDING COMPANY Directeur Général 17/08/2025
JP 3E HOLDINGS, INC. Directeur/Membre du Conseil 13/08/2026
Directeur Général -
Directeur Général 01/01/2013
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/11/2016
Fondateur 01/01/2002

Anciens postes connus de Henry Ji

SociétésPosteFin
SCILEX HOLDING COMPANY Président 01/08/2023
░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Henry Ji

Formation de Henry Ji

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

45

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Stratagene Genomics, Inc.

Hongye SD Group LLC

Retail Trade

Commercial Services

Health Technology

Health Technology

Health Technology

🔇